Phase I Study of [177Lu]Lu-DFC413 in Patients With Solid Tumors
IsraelRecruitingPHASE1
Conditions
Pancreatic Ductal Adenocarcinoma · Non-Small Cell Lung Cancer · HR+/HER2- Ductal and Lobular Breast Cancer · Triple Negative Breast Cancer · Colorectal Cancer · Soft Tissue Sarcoma
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Novartis Investigative Site, Montreal, Quebec, Canada
Novartis Investigative Site, Odense C, Denmark
Novartis Investigative Site, Vandœuvre-lès-Nancy, France
Novartis Investigative Site, Essen, Germany
Novartis Investigative Site, Haifa, Israel
Novartis Investigative Site, Tel Aviv, Israel
Novartis Investigative Site, Singapore, Singapore